Bibliographic Details
| Title: |
Trial in progress: Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated metastatic pancreatic cancer. |
| Authors: |
McWilliams, Robert R., Kasi, Pashtoon Murtaza, Foster, Nathan R., Zhu, Mojun, Carr, Ryan Michael, Ma, Wen Wee, Hartgers, Mindy L., Jones, Kayla M., Bartusiewicz, Jacqueline M., Dong, Haidong, Markovic, Svetomir, Alberts, Steven R, Ahn, Daniel H., Babiker, Hani M., Bekaii-Saab, Tanios S., Couch, Fergus |
| Source: |
Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, pTPS780-TPS780, 1p |
| Database: |
Supplemental Index |
